BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

816 related articles for article (PubMed ID: 8826940)

  • 1. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J; Jaurrieta E; Valls C; Benasco C; Rafecas A; Xiol X; Fabregat J; Casanovas T; Torras J; Baliellas C; Ibañez L; Moreno P; Casais L
    Hepatology; 1997 Jun; 25(6):1485-9. PubMed ID: 9185772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
    Ikai I; Arii S; Kojiro M; Ichida T; Makuuchi M; Matsuyama Y; Nakanuma Y; Okita K; Omata M; Takayasu K; Yamaoka Y
    Cancer; 2004 Aug; 101(4):796-802. PubMed ID: 15305412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report.
    Chen MF; Hwang TL; Tsao KC; Sun CF; Chen TJ
    Surgery; 1991 Apr; 109(4):455-8. PubMed ID: 1706892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
    Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
    Kikuchi LO; Paranaguá-Vezozzo DC; Chagas AL; Mello ES; Alves VA; Farias AQ; Pietrobon R; Carrilho FJ
    J Clin Gastroenterol; 2009 Feb; 43(2):191-5. PubMed ID: 19142170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of two cell lines derived from a single hepatocellular carcinoma containing multiploid DNA distribution.
    Chiu JH; Chang HM; Kao HL; Wu LH; Lui WY
    Cancer Detect Prev; 1996; 20(1):43-51. PubMed ID: 8907202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
    Farinati F; Rinaldi M; Gianni S; Naccarato R
    Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic implications of the ploidy pattern of the nuclear DNA in hepatocellular carcinomas].
    Omagari K; Imanishi T; Morikawa S; Nishihata S; Kamiya T; Hayashida K; Tanioka H; Murata I; Makiyama K; Ashihara K
    Gan No Rinsho; 1990 Feb; 36(2):121-6. PubMed ID: 2155330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
    Zhou LX; Yan LN
    Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.
    Adachi E; Maeda T; Kajiyama K; Kinukawa N; Matsumata T; Sugimachi K; Tsuneyoshi M
    Cancer; 1996 May; 77(10):2022-31. PubMed ID: 8640665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G; Lerma E; Climent MA; Seguí MA; Alonso MC; Prat J
    Mod Pathol; 1997 Mar; 10(3):216-22. PubMed ID: 9071729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
    Sangiovanni A; Colombo E; Radaelli F; Bortoli A; Bovo G; Casiraghi MA; Ceriani R; Roffi L; Redaelli A; Rossini A; Spinzi G; Minoli G
    Am J Gastroenterol; 2001 May; 96(5):1575-80. PubMed ID: 11374702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
    Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR
    Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
    J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience].
    He YF; Fan J; Zhou J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Sun J; Xiao YS; Yang GH; Song K; Wang Z; Tang ZY; Wang YQ
    Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1232-5. PubMed ID: 16796877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.